Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | ACACB | O00763 | 1/20 | 0.42 |
| ▸ | ACACA | Q13085 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2926941 | 1.00 | ACE2 (0.46) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL5459892 | 1.00 | ACE2 (0.46) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL9954583 | 1.00 | ACE2 (0.46) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL9955207 | 1.00 | ACE2 (0.46) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL30492127 | 1.00 | ACE2 (0.46) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL6263078 | 1.00 | ACE2 (0.46) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL7530714 | 1.00 | ACE2 (0.46) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL2904077 | 1.00 | ACE2 (0.46) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL3948914 | 1.00 | ACE2 (0.46) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL8882093 | 0.98 | ACE2 (0.43) | ACE2GPR84FFAR1MAPTLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124112-B2 | Such as erythritol, xylitol, sorbitol and glucose; wear resistant makeup | L'OREAL S.A. (FR) | 2012-02-28 | — | — | US | disclosed |
| US-20080233158-A1 | Two-coat makeup product, its uses, and makeup kit comprising the product | L'ORE AL S.A. | 2008-09-25 | — | — | US | disclosed |
| US-20080107697-A1 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one ester of at least one acid and at least one polyol ester | L'OREAL S.A. | 2008-05-08 | — | — | US | disclosed |
| US-20060078519-A1 | Compositions comprising particles of at least one polymer dispersed in a fatty phase | L'OREAL S.A. (FR) | 2006-04-13 | — | — | US | disclosed |
| US-20050287183-A1 | Cosmetic composition comprising at least one apolar wax and a dispersion of polymer particles in a fatty phase | L'OREAL S.A. (FR) | 2005-12-29 | — | — | US | disclosed |
| US-20040247552-A1 | Dispersion of a polymer particle in a liquid fatty phase and containing an ester of a C 1-7 carboxylic acid abd a polyol having at least 4 hydroxyl groups (e.g., erythritol, xylitol, sorbitol and glucose) with a molecular mass of less than 5,000 g/mol.; makeup with staying power | L'OREAL S.A. (FR) | 2004-12-09 | — | — | US | disclosed |
| US-20040234612-A1 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one compound plasticizing the polymer | L'OREAL S.A. (FR) | 2004-11-25 | — | — | US | disclosed |
| US-20040234564-A1 | Two-coat makeup product, its uses, and makeup kit comprising the product | L'OREAL S.A. (FR) | 2004-11-25 | — | — | US | disclosed |
| US-20040228890-A1 | Two-coat cosmetic product, its uses, and makeup kit including the product | L'OREAL S.A. (FR) | 2004-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060078519-A1 | Compositions comprising particles of at least one polymer dispersed in a fatty phase | FABP4, PLIN5, AUP1 | ACE2 4716/4885GPR84 2117/4885FFAR1 9/4885 |
| US-20040234612-A1 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one compound plasticizing the polymer | CUTA, AUP1, PLIN3 | ACE2 4877/4885GPR84 2454/4885FFAR1 43/4885 |
| US-20040228890-A1 | Two-coat cosmetic product, its uses, and makeup kit including the product | CLK2, CLK1, LIPC | ACE2 3941/4885GPR84 2650/4885FFAR1 823/4885 |
| US-20050287183-A1 | Cosmetic composition comprising at least one apolar wax and a dispersion of polymer particles in a fatty phase | CUTA, RO60, APOL1 | ACE2 4708/4885GPR84 895/4885FFAR1 22/4885 |
| US-20040234564-A1 | Two-coat makeup product, its uses, and makeup kit comprising the product | LMTK2, SETD7, CUTA | ACE2 4419/4885GPR84 2573/4885FFAR1 1836/4885 |
| US-20040247552-A1 | Dispersion of a polymer particle in a liquid fatty phase and containing an ester of a C 1-7 carboxylic acid abd a polyol having at least 4 hydroxyl groups (e.g., erythritol, xylitol, sorbitol and glucose) with a molecular mass of less than 5,000 g/mol.; makeup with staying power | CERT1, UGCG, CUTA | ACE2 4873/4885GPR84 2651/4885FFAR1 191/4885 |
| US-20080233158-A1 | Two-coat makeup product, its uses, and makeup kit comprising the product | LMTK2, SETD7, CUTA | ACE2 4410/4885GPR84 2431/4885FFAR1 1948/4885 |
| US-20080107697-A1 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one ester of at least one acid and at least one polyol ester | CUTA, LIPA, ELOVL1 | ACE2 4883/4885GPR84 1236/4885FFAR1 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.